Literature DB >> 3054099

Multimodality detection of metastatic melanoma.

A K Kuan1, F I Jackson, J Hanson.   

Abstract

A retrospective evaluation of radionuclide liver and spleen scintigraphy (LS), ultrasonography (US), and computed tomography (CT) was performed in 88 patients who had pathologically proven cutaneous melanoma. In patients who had all three examinations (n = 24), the matrix analysis showed that CT was significantly more sensitive (0.94) in detecting intra-abdominal metastasis when compared to US (0.62, P less than 0.05) and LS (0.38, P less than 0.01). Sixty-four patients had only US and LS studies. In this group of patients US was found to be more sensitive than LS, 0.88 and 0.54 respectively (P less than 0.01). Furthermore, when CT was compared with US, CT was shown to detect metastases significantly earlier than US (P = 0.03). Overall, CT provided the most accurate means for detecting the intra-abdominal metastases of cutaneous melanoma.

Entities:  

Mesh:

Year:  1988        PMID: 3054099      PMCID: PMC1291801          DOI: 10.1177/014107688808101009

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  9 in total

1.  Comparison of scintigraphy, sonography, and computed tomography in the evaluation of hepatic neoplasms.

Authors:  J H Snow; H M Goldstein; S Wallace
Journal:  AJR Am J Roentgenol       Date:  1979-06       Impact factor: 3.959

2.  Correlation of computed tomography, gray scale ultrasonography, and radionuclide imaging of the liver in detecting space-occupying processes.

Authors:  P J Bryan; W M Dinn; Z D Grossman; B W Wistow; J G McAfee; S A Kieffer
Journal:  Radiology       Date:  1977-08       Impact factor: 11.105

3.  Screening for diffuse and focal liver disease: the case for hepatic sonography.

Authors:  E Lewis
Journal:  J Clin Ultrasound       Date:  1984-02       Impact factor: 0.910

4.  Screening for diffuse and focal liver disease: the case for hepatic scintigraphy.

Authors:  E C McClees; R K Gedgaudas-McClees
Journal:  J Clin Ultrasound       Date:  1984-02       Impact factor: 0.910

Review 5.  Radiocolloid liver scintigraphy. A choice and an echo.

Authors:  A B Ashare
Journal:  Radiol Clin North Am       Date:  1980-08       Impact factor: 2.303

6.  Diagnostic testing for radiation treatment planning of malignant melanoma with special emphasis on CT scanning.

Authors:  A V Strauss; A Dritschilo; B L Carter; L Nathanson; A J Piro
Journal:  Comput Tomogr       Date:  1981 Jan-Mar

7.  Gray scale ultrasonography in the evaluation of metastatic melanoma.

Authors:  M E Bernardino; H M Goldstein
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

8.  Adjuvant chemotherapy in the management of primary malignant melanoma.

Authors:  P Banzet; C Jacquillat; J Civatte; A Puissant; J Maral; C Chastang; L Israel; S Belaich; J C Jourdain; M Weil; G Auclerc
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

9.  A comparison of noninvasive imaging modalities in the melanoma patient.

Authors:  M J Doiron; M E Bernardino
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

  9 in total
  2 in total

1.  "Melanoma inhibitory activity" (MIA): a promising serological tumour marker in metastatic uveal melanoma.

Authors:  I W Reiniger; U C Schaller; C Haritoglou; R Hein; A K Bosserhoff; A Kampik; A J Mueller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

Review 2.  Proteomics of uveal melanoma: a minireview.

Authors:  Søren K O Abildgaard; Henrik Vorum
Journal:  J Oncol       Date:  2013-09-03       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.